We are headquartered at the Empire State Building in New York City and are investigating Entero Therapeutics, Inc. (NASDAQ: ENTO), relating to the proposed merger with Journey Therapeutics, Inc. Under ...

Entero Therapeutics (ENTO) has entered into a binding term sheet for a reverse merger transaction with Journey Therapeutics. Upon completion of ...

Ademi LLP is investigating Entero (Nasdaq: ENTO) for possible breaches of fiduciary duty and other violations of law in its transaction with Journey . Click here to learn how to join our investigation ...

Lee Chia-lin (李佳琳), deputy director of the CDC's Epidemic Intelligence Center, at a news conference on Tuesday (Nov. 12) noted enterovirus outpatient and emergency room visits from Nov. 3–9 increased ...

Accumulated cases of serious flu complications and flu-related deaths have hit a decade high this flu season, the Centers for Disease Control (CDC) said yesterday, as it reported 20,913 hospital ...

[10,11,12] Intrauterine exposure to maternal enterovirus infection has recently been reported to be associated with the pathogenesis of type 1 diabetes. [4,13,14,24] Two of these studies comprised ...

Reliance Power, Nykaa, 3M India, Sula Vineyards, BASF India, Natco Pharma, and Rattanindia Enterprises are among other firms ...

PrivateThe Q2 earnings season has crossed the peak and is now nearing the end of the season. Out of 4699 companies listed on exchanges, 1852 companies have already declared their quarterly financials ...

After laying off all nonessential workers and halting nonessential R&D work this summer, Entero Therapeutics is inking a reverse merger with antibody drug conjugate (ADC) rival biotech Journey ...

Stocks like Shree Cement, Ramco Cements, Insecticides India, Jubilant Foodworks, Hindustan Copper, National Fertilizers, HMA ...

In the wake of a historic U.S. election, global markets have shown robust performance, with major indices like the S&P 500 and Nasdaq Composite reaching record highs amid expectations of favorable ...